Home/Filings/4/0000950170-25-010004
4//SEC Filing

Pandite Arundathy N. 4

Accession 0000950170-25-010004

CIK 0001680367other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 6:04 PM ET

Size

6.8 KB

Accession

0000950170-25-010004

Insider Transaction Report

Form 4
Period: 2025-01-25
Pandite Arundathy N.
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2025-01-28+206,200206,200 total
    Exercise: $1.18Exp: 2035-01-28Common Stock (206,200 underlying)
  • Tax Payment

    Common Stock

    2025-01-25$1.16/sh3,211$3,725206,265 total
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 206,200 shares of the Issuer's common stock, one quarter of which will vest on January 28, 2026, with the remaining three quarters vesting in equal monthly installments through January 28, 2029, subject to the Reporting Person's continued service to the Issuer.

Documents

1 file

Issuer

Shattuck Labs, Inc.

CIK 0001680367

Entity typeother

Related Parties

1
  • filerCIK 0001827232

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 6:04 PM ET
Size
6.8 KB